Q32 Bio Inc. (QTTB)

NASDAQ

$8.05

$--

(0.00%)

Pre-Market

Q32 Bio Inc. (QTTB) Live Price Chart

Last updated: ⁦2026-10-09 08:02:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Q32 Bio Inc. (QTTB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.05, with a market capitalization of $237.86M and a P/E ratio of 7.13. Over the past 52 weeks, its price has ranged from $1.91 to $23.57. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$237.86M
Open	$8.05
Day's High	$53.79
Day's Low	$1.35
Previous Close	$8.09
Volume	1.00
Average Volume	1.35M
P/E Ratio	7.13
52-Week High	$23.57
52-Week Low	$1.91
Dividend Yield	--
Earnings Date	--

Q32 Bio Inc. (QTTB) Pre-Market Stock Price

Q32 Bio Inc. (QTTB) is trading at $8.05 in pre-market trading as of 2026-10-09 08:01:00, down 0.49% ($0.04) from the previous close of $8.09

Pre-market trading shows how investors are pricing QTTB before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Q32 Bio Inc. (QTTB) 7-Day Stock Price Change

Over the past seven days, Q32 Bio Inc. (QTTB) moved from $8.27 to $8.05, representing a decline of 2.66% ($0.22).

The stock traded between $7.62 and $10.40 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 1.93 million shares, up versus the previous seven-day period, indicating higher trading activity.

QTTB 52-Week Price Position

Position in Range: 28.4%

52W Low$1.91

52W High$23.57

QTTB is currently trading at $8.05, placing it 28.4% of the way from its 52-week low of $1.91 to its 52-week high of $23.57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Q32 Bio Inc. (QTTB)?

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Q32 Bio Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	22
Exchange	NASDAQ
Company Website	https://www.q32bio.com

How to Buy Q32 Bio Inc. (QTTB) Stock on MEXC

Eligible investors can buy real shares of Q32 Bio Inc. (QTTB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for QTTB and Place Your Order

Open the RealStocks trading page and search for QTTB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Q32 Bio Inc. (QTTB) stock price today?

Q32 Bio Inc. (QTTB) is currently trading at $ 8.05, down 0.49% ($0.04) from the previous close of $ 8.09. Intraday prices update in real time during regular trading hours.

2.Is QTTB stock going up or down today?

As of 2026-10-09 08:01:00, QTTB is trading at $ 8.05, down 0.49% ($0.04) from its previous close of $ 8.09. The stock has traded between $ 1.35 and $ 53.79 during today’s regular session. Past price movements do not guarantee future results.

3.What is QTTB pre-market price?

As of 2026-10-09 08:01:00, QTTB is trading at $ 8.05 in pre-market trading, down 0.49% ($0.04) from the previous close of $ 8.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is QTTB after-hours price?

As of 2026-10-09 08:01:00, QTTB is trading at $ 8.05 in after-hours trading, down 0.51% ($0.04) from the regular-session close of $ 8.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is QTTB stock trading now?

QTTB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does QTTB sit relative to its 52-week high and low?

Over the past 52 weeks, QTTB has traded between a low of $ 1.91 and a high of $ 23.57. At $ 8.05, the stock is positioned 28.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Q32 Bio Inc. in?

Q32 Bio Inc. (QTTB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Q32 Bio Inc.'s market capitalization and where is it listed?

Q32 Bio Inc. is listed on the NASDAQ exchange with a market capitalization of $ 237.86M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is QTTB valued in terms of P/E ratio and EPS?

QTTB trades at a P/E ratio of 7.13, based on trailing-twelve-month EPS of $ 1.13. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Q32 Bio Inc. pay a dividend?

Q32 Bio Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.